Presenter's Information

Bon-Kwon Koo, MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. Conceptual Evolution of Bifurcation PCI
  2. Case 4. CT-Derived FFR for All Coronary Lesions
  3. AI-Enabled Vulnerable Plaque Characterization
  4. The Psychological Evolution of Side Branch PCI
  5. Physiology-Guided Decision-Making for Complex PCI
  6. Physiologic Approach For Non-LM Bifurcation Disease
  7. Long-term Prognostic Impact of Fractional Flow Reserve After Coronary Stenting: Insights From the Internation Post-PCI FFR Extended Registry
  8. FFR vs. IVUS to Guide PCI
  9. How Do I Know This Side Branch is Important
  10. Case 2. Physiology Guided PCI
  11. Sex Differences in Plaque Characteristics and Myocardial Mass: Implications for Physiologic Significance
  12. CT FFR : We Do Not Need Invasive Angiography
  13. Imaging Based Coronary Physiology in the Clinical Practice: CTFFR and AngioFFR
  14. Make it Simple: Practice with Invasive Physiology in Complex PCI
  15. Bifurcation PCI at the Crossroads: New Physiology-Guided Decision-Making 2021
  16. Smart PCI with Advanced Co-Registration System
  17. FLAVOUR: Physiology or Imaging for Revascularization Strategy
  18. How to Make Optimal Hyperemia: From Adenosine to Contrast
  19. Non-Invasive Hemodynamic Assessment for ACS Risk
  20. Coronary Physiology Perspective
  21. Physiologic Assessment for Bifurcation Lesion
  22. Similarities and Dissimilarities of FFR, iFR and Resting Pd/Pa
  23. Bifurcation PCI with Physiologic Index: FFR, Contrast FFR, Pd/Pa, and iFR - When, How, and What?
  24. Role of FFR in ACS (uAP, NSTEMI, and STEMI): Still Doubtful?
  25. iFR as the Gold Standard Index!
  26. How to Make Optimal Resting and Hyperemic Status for Coronary Physiologic Assessment
  27. Physiology Guided Complex PCI
  28. What Really Matter in Bifurcation PCI: Technique or Concept
  29. Future Clinical Role of IMR or Microcirculation Study
  30. Why Should Be FFR Believer in Non-LM and LM Bifurcation PCI
  31. EMERALD Study: Exploring the MEchanism of the Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and ComputationaL Fluid Dynamics
  32. How May FFR Help in LM PCI?
  33. Bifurcation PCI; Why Imaging and Functional Guidance?
  34. How PCI? Function-Guided Approach
  35. Physiology Assesment; FFR, CFR, IFR, IMR
  36. FFRct: Present and Future
  37. Real World Use of BES in Korea: From the Host Biolimus Registry
  38. Vulnerability Assessment Using Physiologic Indices
  39. Bifurcation
  40. Hemodynamic Force and Coronary Plaque: Theoretical Evaluation of Mechanistic Effect
  41. Bifurcation PCI: Is It a Matter of Technique or Concept?
  42. Case 2: Bifurcation, Tandem and Diffuse Disease
  43. FFR-Guided Bifurcation Treatment: Treat-or-Not Treat and Bifurcation Techniques
  44. [Integrated Use of FFR and IVUS: Case Based Learning] Non-Left Main
  45. Mechanistic Link Between Hemodynamics and ACS
  46. FFRct: Present and Future
  47. Novel Non-Invasive Indices to Define Hemodynamic Forces Acting on Coronary Plaque
  48. FFR Assessment for Complex Lesion (LM, Bifurcation, Tandem, Etc.)
  49. Sketch for FFR Basics, Artifacts, Pitfalls, and Grey Zones
  50. FFR in Bifurcation Lesions: We Should Be More Physiologic Than FFR!
  51. Advanced Application of a Pressure Wire: Dobutamine Stress-FFR, Wedge Pressure…
  52. FFR vs. Acute Coronary Syndrome: Is There Any Link?
  53. How to Practically Use FFR for Left Main Disease?
  54. FFR in Bifurcation Lesions: We Should Be More Physiologic Than FFR !
  55. Hyperemia
  56. FFR CT in Progression
  57. Non-Left Main PCI
  58. FFR Digest: Evolving from PCI to CABG
  59. Step-by-Step Approach in Non-LM Bifurcation PCI Using FFR and IVUS
  60. [Debate: Functional Evaluation Is Necessary] Yes, We Need a Function-guidance.
  61. From CTA to CT-FFR
  62. How to Utilize FFR and IVUS in Non-LM Bifurcation PCI?
  63. Multivessel & Bifurcation
  64. Non-LM PCI
  65. Pharmacologic Agents for Maximal Hyperemia
  66. FFR at CathLab Today: Moving Closer, But Gaps Remain.
  67. Function-guided Bifurcation PCI
  68. Morphologic vs. Functional Assessment for Bifurcation Lesion
  69. Why FFR and Why Not FFR in Bifurcation Lesions
  70. Which Is the Best Modality for the Ischemia Guided Functional Angioplasty?: FFR, Thallium SPECT, FFR CT and Others
  71. FFR-guided Optimization of Bifurcation PCI
  72. Predictors of Restenosis and Stent Thrombosis in Bifurcation PCI
  73. DISCOVER-FLOW
  74. Usefulness of IVUS and FFR in Non-LM Bifurcation PCI
  75. Innovation in Medicine: The Korean Approach
  76. FFR-Guided Provisional Stenting: Ischemia or Stenosis
  77. How is FFR Helpful to Treat the Bifurcating Lesions?
  78. FFR: Basics, Artifacts and Pitfalls
  79. Case Based Learning
  80. FFR Evalution of Bifurcating Lesion
  81. FFR in Bifurcation Lesion
  82. Diffuse, Serial and Multiple Stenosis
  83. Pitfalls with FFR Measurements
  84. Physiologic Insight of a Bifurcation Lesion
  85. Technical Approach in True Bifurcation Lesions; What We Have Learned from FFR
  86. Clinical Application of FFR in PCI of Bifurcation Lesion
  87. Fractional Flow Reserve Guided Jailed Side Branch Intervention in Bifurcation Lesions
Conference Slides
Category